Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
Clinical trial NCT03459469 · COMPLETED
Trial details
- NCT number
- NCT03459469
- Sponsor
- Iterion Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-15
- Primary completion
- 2022-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.